NEW YORK (GenomeWeb News) - TriLink Biotechnologies, a maker of customized nucleic acid products, said today it has received a $100,000 Phase I Small Business Innovation Research grant from the National Institutes of Health to study a novel approach to PCR activation.
 
The NIH's National Institute of General Medical Sciences awarded the grant.
 
The company said its so-called Hot Start PCR method uses chemically modified triphosphates that inhibit DNA polymerase activity until a thermal activation step.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The US National Institutes of Health and the Food and Drug Administration have proposed changing gene therapy oversight, the Associated Press reports.

Nature News reports that the Salk Institute has asked for the scope of a gender discrimination lawsuit brought against it to be narrowed.

CNBC reports that the sequencing startup Veritas aims to sequence individuals who fall at extremes.

In PLOS this week: genotyping of indigenous North African goats, program to simulate evolve and resequencing studies, and more.